Yahoo Finance

Operations: EXEL Industries generates its revenue primarily from the Spraying for Agriculture and Industry segment, amounting to approximately €1.10 billion.

EXEL Industries, a notable player in the machinery sector, has demonstrated robust earnings growth of 30.3% annually over the past five years, though its recent 39.4% increase lagged behind the industry's 43.6%. The company is trading at a substantial discount, about 51.2% below its estimated fair value, suggesting potential for upside if market conditions align. However, it faces challenges with a net debt to equity ratio of 42%, which is considered high despite interest payments being well covered by EBIT at a ratio of 9.2x. Despite these hurdles, EXEL's high-quality earnings and profitability provide some stability amidst financial pressures.

• Click here and access our complete health analysis report to understand the dynamics of EXEL Industries.

• Gain insights into EXEL Industries' past trends and performance with our Past report.

Savencia

Simply Wall St Value Rating: ★★★★★★

Overview: Savencia SA is a company that produces, distributes, and markets dairy and cheese products across France, Europe, and internationally with a market capitalization of €692.76 million.

Operations: Savencia derives its revenue primarily from the production, distribution, and marketing of dairy and cheese products across various regions. The company's financial performance is influenced by its ability to manage costs associated with these operations.

Savencia, a noteworthy player in the French food industry, has shown impressive earnings growth of 114.7% over the past year, outpacing the sector's average of 67.3%. Despite a significant one-off loss of €43.6M affecting recent results, it remains profitable with an interest coverage ratio of 32.3x by EBIT, indicating strong financial health. The company's debt to equity ratio has improved from 88.6% to 69.5% over five years, reflecting effective debt management strategies. Trading at approximately 76.7% below its estimated fair value suggests potential undervaluation in comparison to peers and industry standards.

• Take a closer look at Savencia's potential here in our health report.

• Review our historical performance report to gain insights into Savencia's's past performance.

Taking Advantage

• Click through to start exploring the rest of the 36 Euronext Paris Undiscovered Gems With Strong Fundamentals now.

• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.

• Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ENXTPA:ALCLA ENXTPA:EXE and ENXTPA:SAVE.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com